Press coverage about LHC Group (NASDAQ:LHCG) has been trending somewhat positive on Sunday, Accern reports. The research group scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. LHC Group earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned press coverage about the health services provider an impact score of 47.4800613586779 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:
- Company Profile for LHC Group (finance.yahoo.com)
- $0.60 EPS Expected for LHC Group (LHCG) This Quarter (americanbankingnews.com)
- LHC Group’s CMS Star Ratings Continue to Lead Home Healthcare Industry (tmcnet.com)
- The LHC Group (LHCG) Stock Rating Lowered by BidaskClub (campdesrecrues.com)
- LHC Group, Inc. :LHCG-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017 (finance.yahoo.com)
A number of equities research analysts have weighed in on the stock. Royal Bank Of Canada reiterated a “buy” rating and set a $69.00 target price on shares of LHC Group in a research note on Monday, May 15th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $68.00 target price (up from $55.00) on shares of LHC Group in a research note on Monday, May 8th. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. Jefferies Group LLC boosted their target price on shares of LHC Group from $56.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, May 15th. Finally, BidaskClub lowered shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $65.75.
Shares of LHC Group (NASDAQ:LHCG) opened at 63.87 on Friday. LHC Group has a 12 month low of $32.04 and a 12 month high of $69.35. The stock’s 50 day moving average is $63.64 and its 200-day moving average is $56.84. The company has a market cap of $1.17 billion, a P/E ratio of 28.26 and a beta of 0.77.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The company had revenue of $260.20 million during the quarter, compared to analysts’ expectations of $254.10 million. During the same quarter in the previous year, the company earned $0.52 earnings per share. The firm’s revenue for the quarter was up 15.1% on a year-over-year basis. On average, equities analysts forecast that LHC Group will post $2.39 EPS for the current year.
In other news, Director Coliseum Capital Management, L sold 8,632 shares of LHC Group stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.25, for a total value of $520,078.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Donald Dwayne Stelly sold 3,181 shares of LHC Group stock in a transaction dated Thursday, June 8th. The shares were sold at an average price of $64.97, for a total transaction of $206,669.57. Following the completion of the sale, the chief operating officer now owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last quarter, insiders sold 554,839 shares of company stock worth $34,333,811. Company insiders own 14.80% of the company’s stock.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.